Kathryn E. Luker

6.1k citations
76 papers · 4.9k indexed · 1 hit paper · h-index 36

Impact in

  • Oncology top 1%
    • Chemokine receptors and signaling
    • Cancer Cells and Metastasis
    • Cytokine Signaling Pathways and Interactions
  • Immunology top 2%
    • Immunotherapy and Immune Responses
    • interferon and immune responses

Papers in

    • Cell Image Analysis Techniques 8
    • Chemokine receptors and signaling 19
    • Cancer Cells and Metastasis 9

Kathryn E. Luker

76 papers receiving 4.8k citations

Hit Papers

CXCR4 Regulates Growth of Both Primary and Metastatic Breast Cancer 2004 · 586 citations
5862004202620112018100200300400500

Peers

Kathryn E. Luker
Comparison fields: 5 of 130
  • Oncology 2.0k
  • Immunology 1.4k
  • Biophysics 249
  • Immunology and Allergy 182
  • Biomedical Engineering 1.2k
Replace Philippe Bousso with:
Philippe Bousso France
Michael H. Bachmann United States
Jackson G. Egen United States
Björn Önfelt Sweden
Jun Huang United States
Tri Giang Phan Australia
Pirjo Laakkonen Finland
Jennifer R. Cochran United States
Steven Fiering United States
Jody Rosenblatt United States
Kathryn E. Luker relative to Philippe Bousso France Philippe Bousso's profile →
Citations per field
00.5×1.5×2.2×
Philippe Bousso · 1×
Citations per year

Countries citing papers authored by Kathryn E. Luker

Since Specialization
Citations

This map shows the geographic impact of Kathryn E. Luker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn E. Luker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn E. Luker more than expected).

Fields of papers citing papers by Kathryn E. Luker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn E. Luker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn E. Luker. The network helps show where Kathryn E. Luker may publish in the future.

Co-authors

The 25 scholars most cited alongside Kathryn E. Luker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kathryn E. Luker Line = papers co-authored together Kathryn E. Luker links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20244
2 20241
3 20242
4 202319
5 20236
6 20229
7 201549
8 20151
9 201235
10 201166
11 201136
12 201056
13 201018
14 2009254
15 200846
16 200735
17 2007294
18 200727
19 200595
20 200068

About Kathryn E. Luker

Kathryn E. Luker is a scholar working on Biophysics, Oncology, Immunology, Virology and Molecular Biology, having authored 76 papers that have together received 4.9k indexed citations. Recurring topics across this work include Chemokine receptors and signaling (19 papers), Immunotherapy and Immune Responses (14 papers), bioluminescence and chemiluminescence research (12 papers), 3D Printing in Biomedical Research (11 papers), Cancer Cells and Metastasis (9 papers), interferon and immune responses (8 papers), Cell Image Analysis Techniques (8 papers) and Virus-based gene therapy research (6 papers). The work is most often cited by research in Oncology (2.0k citations), Immunology (1.4k citations), Biophysics (249 citations), Immunology and Allergy (182 citations) and Biomedical Engineering (1.2k citations). Kathryn E. Luker has collaborated with scholars based in United States, China and France. Frequent co-authors include Gary D. Luker, David Piwnica‐Worms, Joel R. Garbow, Erin Jackson, Matthew C. Smith, Julie L. Prior, Shuichi Takayama, Mudit Gupta, Christina M. Pica and Alnawaz Rehemtulla. Their work appears in journals such as Virology, Proceedings of the National Academy of Sciences, Molecular Imaging, Neoplasia and Small.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026